Announcement
23 Apr 2026
: M42 advances global healthcare ambitions with Diaverum’s landmark Brazil acquisition

M42's clinical genomics laboratory, delivers precision diagnostics that turn genetic and genomic data into meaningful insights for patient care. Powered by one of the world’s largest sequencing ecosystems, the lab combines advanced infrastructure, secure data systems and sophisticated bioinformatics to provide accurate and timely testing at scale. From targeted panels to whole genome sequencing, Biogenix Labs gives clinicians and patients results they can trust, helping shape care that is predictive, preventive and precise.